서울대학교 중앙도서관
S-Space 소개
My S-Space
로그인이 필요합니다.
Login

S-Space

Browse

Subject

Jump to a point in the index
Or type in a year

  • Sort by
  • In order
  • Results/Page
  • Authors/record

Showing results 1 to 16 of 16

Issue DateTitle / Author(s) / CitationFileAltmetrics
2009-07
Synergistic anti-tumor efficacy of lovastatin and protein kinase C-beta inhibitor in hepatocellular carcinoma

Kim, Won; Yoon, Jung-Hwan; Kim, Jung-Ryul; Jang, In-Jin; Bang, Yung-Jue; Kim, Yoon-Jun; Lee, Hyo-Suk

Cancer Chemotherapy and Pharmacology, Vol.64 No.3, pp.497-507

DOI
2011-07
Prognostic implication of 18F FDG-PET in patients with extrahepatic metastatic hepatocellular carcinoma undergoing systemic treatment, a retrospective cohort study

Shin, Dong-Yeop; Han, Sae-Won; Oh, Do-Youn; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue

Cancer Chemotherapy and Pharmacology, Vol.68 No.1, pp.165-175

DOI
2012-02
Enhancement of hexokinase II inhibitor-induced apoptosis in hepatocellular carcinoma cells via augmenting ER stress and anti-angiogenesis by protein disulfide isomerase inhibition
DOI
2012-02
Enhancement of hexokinase II inhibitor-induced apoptosis in hepatocellular carcinoma cells via augmenting ER stress and anti-angiogenesis by protein disulfide isomerase inhibition.
DOI
2012-02
Augmentation of Chemotherapeutic Infusion Effect by TSU-68, an Oral Targeted Antiangiogenic Agent, in a Rabbit VX2 Liver Tumor Model

Kim, Hyo-Cheol; Chung, Jin Wook; Choi, Seung Hong; Im, Seock-Ah; Yamasaki, Yasundo; Jun, Suryoung; Jae, Hwan Jun; Park, Jae Hyung

CardioVascular and Interventional Radiology, Vol.35 No.1, pp.168-175

DOI
2012-03
Risk Factors, Clinical Features, and Prognosis of the Hepatocellular Carcinoma with Peritoneal Metastasis

Kwak, Min-Sun; Lee, Jeong-Hoon; Yoon, Jung-Hwan; Yu, Su Jong; Cho, Eun Ju; Jang, Eun Sun; Kim, Yoon Jun; Lee, Hyo-Suk

DIGESTIVE DISEASES AND SCIENCES Vol.57 No.3, pp. 813-819

DOI
2012-06
Prognostic implications of tumor vascularity and its relationship to cytokeratin 19 expression in patients with hepatocellular carcinoma
DOI
2015-04
Recurrence-associated pathways in hepatitis B virus-positive hepatocellular carcinoma
view fileDOI
2016-01
Comparison of tumor vascularity and hemodynamics in three rat hepatoma models
DOI
2016-02
Comparison of tumor vascularity and hemodynamics in three rat hepatoma models
DOI
2018-01
Non-invasive monitoring of the therapeutic response in sorafenib-treated hepatocellular carcinoma based on photoacoustic imaging

Lee, Seunghyun; Kim, Jung Hoon; Lee, Jae Hwan; Lee, Jeong Hwa; Han, Joon Koo

European Radiology, Vol.28 No.1, pp.372-381

DOI
2018-03
A phase II trial of S-1 and oxaliplatin in patients with advanced hepatocellular carcinoma
DOI
2020-09
Ramucirumab and durvalumab for previously treated, advanced non-small-cell lung cancer, gastric/gastro-oesophageal junction adenocarcinoma, or hepatocellular carcinoma: An open-label, phase Ia/b study (JVDJ)
DOI
2020-11
Laparoscopic versus Open Hepatectomy for Hepatocellular Carcinoma in Elderly Patients: A Single-Institutional Propensity Score Matching Comparison
DOI
2021-03
Feasibility of Solo Single-Incision Laparoscopic Surgery in Non-anatomical Minor Liver Resection: a Propensity Score-Matched Analysis

Hyun, In Gun; Choi, YoungRok; Han, Ho-Seong; Yoon, Yoo-Seok; Cho, Jai Young; Kim, Kil Hwan; Han, Sunjong

Journal of Gastrointestinal Surgery, Vol.25 No.3, pp.681-687

DOI
2022-02
Role of radiotherapy in Barcelona Clinic Liver Cancer stage C hepatocellular carcinoma treated with sorafenib

Chang, Won Ick; Kim, Byoung Hyuck; Kim, Yoon Jun; Yoon, Jung-Hwan; Jung, Yong Jin; Chie, Eui Kyu

Journal of Gastroenterology and Hepatology, Vol.37 No.2, pp.387-394

DOI
1